Browsing: VKTX

Although Viking TherapeuticsVKTX isn’t officially on the auction block, investors are increasingly viewing it as a potential acquisition target. This perception stems from the company’s rapidly expanding obesity franchise, driven by the late-stage development of VK2735, the addition of a new obesity candidate and an upcoming clinical data readout that could further bolster investor confidence

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide